منابع مشابه
Naltrexone implants In the first randomised controlled trial of naltrexone implants,
In the first randomised controlled trial of naltrexone implants, Kunøe et al identify two inclusion criteria in their methodology: being an in-patient and being 18 years or above. Exclusion criteria are given as psychosis, pregnancy and serious hepatic disease. Of 667 possible participants, 480 are excluded. In the results, the term ‘ineligibility’ is used to describe not completing treatment, ...
متن کاملNaltrexone implants In the first randomised controlled trial of naltrexone implants,
In the first randomised controlled trial of naltrexone implants, Kunøe et al identify two inclusion criteria in their methodology: being an in-patient and being 18 years or above. Exclusion criteria are given as psychosis, pregnancy and serious hepatic disease. Of 667 possible participants, 480 are excluded. In the results, the term ‘ineligibility’ is used to describe not completing treatment, ...
متن کاملNaltrexone implants In the first randomised controlled trial of naltrexone implants,
In the first randomised controlled trial of naltrexone implants, Kunøe et al identify two inclusion criteria in their methodology: being an in-patient and being 18 years or above. Exclusion criteria are given as psychosis, pregnancy and serious hepatic disease. Of 667 possible participants, 480 are excluded. In the results, the term ‘ineligibility’ is used to describe not completing treatment, ...
متن کاملOpen Label Trial of Naltrexone Implants: Measuring Blood Serum Levels of Naltrexone
The usefulness of oral naltrexone has been limited by compliance. Sub-cutaneous implants would seem to offer a solution to this problem and improve long-term outcomes. The aim of the present study was to compare levels of blood serum naltrexone of patients who had received a naltrexone implant after detoxification to a number of dependent variables of interest. These dependent variables include...
متن کاملNaltrexone implants after in-patient treatment for opioid dependence: randomised controlled trial.
BACKGROUND Naltrexone has considerable potential in helping to prevent relapse in heroin dependency. A longer-lasting formulation for naltrexone treatment is desirable to further reduce non-adherence and relapse during treatment of opiate dependence. AIMS To evaluate the safety and effectiveness of a 6-month naltrexone implant in reducing opioid use after in-patient treatment. METHOD A grou...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Psychiatry
سال: 2010
ISSN: 0007-1250,1472-1465
DOI: 10.1192/bjp.196.1.77